image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 9 days, don't miss out!

4Imprint - Raises guidance; shares hit £56!

March 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FOUR
  • Price:
  • 5480p
The shares spiked to £56 after promotional products supplier 4Imprint yet again raised full year pretax profit guidance by 8% to over £140m while it also expects revenue of c. £1.33 billion, an increase of 16% compared to the US$1.14bn in 2022. The rate of order book growth slowed during the year, reflecting tougher comps from April. Order counts increased 22% in the first four months, falling to +13% for the full year. Gross margin should increase from 28.2% to 30.4%, in part thanks to improved delivery and lower customer credits. The “operational progress” noted refers to investment in selling and admin functions and screen printing, adding 50% additional capacity (to 450k sq. ft.) at its Oshkosh plant while supporting fu ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author